[PubMed ID: 24176233]
Key Takeaways CVS Caremark covers Wegovy on approximately 18% of commercial employer-sponsored plans as of Q1 2026, typically requiring step therapy and prior authorization Most CVS Caremark plans place Wegovy on Tier 3 (preferred brand) or exclude it entirely, with monthly copays ranging from $25 to $1,349 depending on plan design Prior authorization approval rates for Wegovy through CVS Caremark average 34% on first submission, with denials most commonly citing failure to meet BMI thresholds or lack of documented lifestyle intervention Compounded semaglutide costs $297 to $347 per month through platforms like FormBlends and does not require insurance coverage or prior authorization Direct answer (40-60 words) CVS Caremark covers Wegovy on a minority of commercial plans in 2026, with coverage limited to patients meeting strict criteria: BMI 30+ (or 27+ with comorbidity), documented 90-day lifestyle intervention, and successful completion of step therapy

The Drip & Swirl: The Drip technique is to add the solvent slowly, dropwise, against the glass wall of the vial
Social platforms are filled with dramatic before-and-after photos, but the reality is often more nuanced than what you see online
Over two immersive days, providers learn how to select the right technology for specific patient demographics, design treatment plans for todays patients, and create packages or bundles that drive measurable ROI